Tokyo, Japan

Kouzo Sawada

This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2012.


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kouzo Sawada: Innovator in Pharmaceutical Chemistry

Introduction

Kouzo Sawada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that have therapeutic applications.

Latest Patents

One of his notable patents is related to amide derivatives as ROCK inhibitors. This invention focuses on novel amide derivatives and salts that act as inhibitors of Rho-associated protein kinase (ROCK). The patent outlines a pharmaceutical composition that includes these compounds and describes methods for their therapeutic use in treating or preventing ROCK-related diseases. Kouzo Sawada holds 1 patent in this area.

Career Highlights

Kouzo Sawada is currently employed at Astellas Pharma GmbH, a leading global pharmaceutical company. His work at Astellas has allowed him to engage in cutting-edge research and development, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Kouzo has collaborated with several talented individuals, including Tatsuya Zenkoh and Junko Watanabe. These collaborations have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Kouzo Sawada is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative approach to developing ROCK inhibitors showcases his commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…